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Abstract
Background: There are differences in the literature regarding outcomes of premature small-for-gestational-age
(SGA) and appropriate-for gestational-age (AGA) infants, possibly due to failure to take into account gestational
age at birth.
Objective: To compare mortality and respiratory morbidity of SGA and AGA premature newborn infants.
Design/Methods: A retrospective study was done of the 2,487 infants born without congenital anomalies at ≤36
weeks of gestation and admitted to the neonatal intensive care unit (NICU) at John Dempsey Hospital, between
Jan. 1992 and Dec. 1999. Recent (1994–96) U.S. birth weight percentiles for gestational age (GA), race and gender
were used to classify neonates as SGA (<10th percentile for GA) or AGA (10th–90th percentile for GA). Using
multivariate logistic regression and survival analyses to control for GA, SGA and AGA infants were compared for
mortality and respiratory morbidity.
Results: Controlling for GA, premature SGA infants were at a higher risk for mortality (Odds ratio 3.1, P =
0.001) and at lower risk of respiratory distress syndrome (OR = 0.71, p = 0.02) than AGA infants. However
multivariate logistic regression modeling found that the odds of having respiratory distress syndrome (RDS)
varied between SGA and AGA infants by GA. There was no change in RDS risk in SGA infants at GA ≤ 32 wk
(OR = 1.27, 95% CI 0.32 – 1.98) but significantly decreased risk for RDS at GA > 32 wk (OR = 0.41, 95% CI 0.27
– 0.63; p < 0.01). After controlling for GA, SGA infants were observed to be at a significantly higher risk for
developing chronic lung disease as compared to AGA infants (OR = 2.2, 95% CI = 1.2 – 3.9, P = 0.01). There was
no significant difference between SGA and AGA infants in total days on ventilator. Among infants who survived,
mean length of hospital stay was significantly higher in SGA infants born between 26–36 wks GA than AGA infants.
Conclusions: Premature SGA infants have significantly higher mortality, significantly higher risk of developing
chronic lung disease and longer hospital stay as compared to premature AGA infants. Even the reduced risk of
RDS in infants born at ≥32 wk GA, (conferred possibly by intra-uterine stress leading to accelerated lung
maturation) appears to be of transient effect and is counterbalanced by adverse effects of poor intrauterine
growth on long term pulmonary outcomes such as chronic lung disease.
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Background
Small for gestational age infants (SGA) represent a signif-
icant percentage of infants admitted to the Neonatal
Intensive care units (NICU). There are a number of studies
comparing premature small for gestational age (SGA)
infants with appropriate for gestational age (AGA) infants,
for differences in their mortality and morbidity [1-8]
Although there is a consensus that premature SGA infants
have higher mortality than AGA infants, the differences in
outcomes regarding respiratory and non-respiratory mor-
bidity are controversial. The discrepancies between differ-
ent studies may partly be explained by variations in
gestational age (GA) of the study populations and by the
studies' failure to stratify the study population by GA.
Moreover, several of these studies used birth weight per-
centile curves from older norms, to determine whether the
infant is SGA or AGA [9-11] and/or did not take into
account the racial differences in birth weight.
The aim of the present study was to compare the respira-
tory outcomes between premature SGA and AGA infants
stratified by gestational age, using the most current US
birth weight percentiles for gestational age by race and
gender. [12]
Methods
This is a retrospective study involving 2,530 infants born
at ≤36 weeks of gestational age and admitted to the NICU
at University Of Connecticut Health Center, Farmington,
CT, between January 1992 and December 1999. Forty-
three infants born with congenital malformations or chro-
mosomal aberrations were excluded from the study and
the remaining 2,487 infants were included in the analyses.
Gestational age was determined based on maternal men-
strual history and early fetal ultrasound. If, rarely, a differ-
ence of more than 2 weeks was observed using the
physical exam based modified Ballard score, then the
newly assessed GA was used. [13]Infants were classified as
SGA (<10th percentile for gestational age), AGA (10th to
90th percentile for gestational age) and LGA (Large for ges-
tational age) (>90th percentile for gestational age) based
on US singleton birth weight percentiles for gestational
age by race and gender. [12]Mortality was based on death
prior to hospital discharge. Respiratory Distress Syndrome
was diagnosed on the basis of clinical presentation and
chest radiographs. [14] Long-term morbidity (Days on
ventilator, BPD, Chronic lung disease and length of hos-
pital stay) was studied only for the infants who survived
≥28 days of life. Days on Ventilator included total number
of days on Bear 750 servo controlled ventilator, Sensor
medics 3100 A High-frequency oscillator and/or Contin-
uous Positive Airway Pressure. BPD was diagnosed based
upon need for any amount of supplemental oxygen at 28
days of life. Chronic lung disease was based upon any sup-
plemental oxygen need at 36 weeks postmenstrual age
[GA at birth (wks) plus weeks after birth]. Length of hospital
stay included total number of days that the infant was in
the NICU before being discharged. The infants were dis-
charged when they were at ≥35 weeks of postmenstrual
age, able to maintain body temperature in open crib, free
of apneic spells for ≥7 days and on full oral feeds. Infants
who were transferred to another hospital were included
and constituted <10% of the group.
Statistics
Univariate analyses, multivariate logistic regression analy-
ses and survival analyses were performed and odds ratio
with 95% confidence intervals were calculated for the
major outcome variables. P value ≤ 0.05 was considered
to be statistically significant.
Results
Patient demographics
Of the 2,487 neonates included in the study, 358 (14.4%)
were classified as SGA, 2,008 (80.7%) were classified as
AGA, 41 (1.6%) were classified as LGA and 80 (3.3%)
could not be classified for incomplete data. The distribu-
tions of GA, birth weight, sex and race distribution along
with maternal factors are shown in table 1. Table 2 shows
distribution of population based on groups classified by
GA at birth (wk).
Mortality
The relationship of mortality between SGA and AGA pre-
mature infants, stratified by GA, is shown in the figure 1.
Controlling for GA, logistic regression analysis showed
that premature SGA neonates were at a higher risk of mor-
tality than premature AGA infants (Odds Ratio 3.1, p =
0.001). Among the 15 SGA infants who died 12 had RDS
(80%), 5 developed pulmonary hemorrhage (33%), 2 suf-
fered from perinatal asphyxia (13%), 2 developed sepsis
Table 1: Distribution of study population based on gender and 
ethnicity
SGA (n = 358) AGA (n = 2008)
Gestational Age (wks) 33.2 ± 2.5 30.9 ± 3.5
Birth weight (gm) 1524.6 ± 466 1753.5 ± 683
Male Sex 197 (55%) 109 (55%)
Race
Whites 270 (75%) 1620 (81%)
African-Americans 42 (12%) 192 (9%)
Hispanics 46 (13%) 196 (10%)
Maternal HTN 8 (2.3%)a 51 (2.6%)b
Antepartum Bleeding 59 (16.8%)a 389 (19.7%)b
Chorioamnionitis 70 (19.9%)a 315 (16.0%)b
Data shown as frequency (%) or mean ± sd a – missing data on 7 
infants, b – missing data on 37 infantsBMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/9
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(13%) and 1 infant each developed intraventricular hem-
orrhage and pneumothorax (6.7%); an infant may have
had more than one diagnosis. Among the 117 AGA
infants who died 101 developed RDS (86.3%), 24 had
pulmonary hemorrhage (20.5%), 5 suffered from perina-
tal asphyxia (4.3%), 26 had sepsis (22.2%), 31 developed
IVH (26.5%) and 34 developed pneumothorax (29.1%).
Among infants who died, the age of death was similar for
SGA and AGA infants (SGA vs. AGA, mean ± sd; 17.1 ±
41.4 days vs. 14.3 ± 32.9 days, p = 0.6).
Respiratory distress syndrome
The relationship of RDS between SGA and AGA premature
infants is shown in the figure 2. Controlling for GA, mul-
tivariate logistic regression analysis showed that prema-
ture SGA infants are at a lower risk for RDS than
premature AGA infants (Odds ratio = 0.71, 95% CI = 0.53
– 0.94; P = 0.02). As shown in table 3, at the lower gesta-
tional age groups (24 – 31 weeks), the incidence of RDS
was not significantly different between the two groups. At
GA 32–34 weeks, SGA infants were observed to be at a
lower risk for having RDS and this difference approached
significance (p = 0.09). However at GA > 34 weeks, the
incidence of RDS in SGA infants was significantly lower
than AGA infants (p < 0.002). Overall, there was no
change in RDS risk in SGA infants at GA ≤ 32 wk (OR =
1.27, 95% CI 0.32 – 1.98) but significantly decreased risk
for RDS at GA > 32 wk (OR = 0.41, 95% CI 0.27 – 0.63; p
< 0.01).
Days on ventilator
After controlling for GA, among the SGA and AGA infants
who survived till discharge, there was no significant differ-
ence in the number of days on ventilator (RR = 0.94, 95%
CI = 0.87 – 1.02; P = 0.13).
Broncho-pulmonary dysplasia
After controlling for GA, among infants who survived
until 28 days of life, SGA infants were observed to be at a
slightly higher risk for developing BPD. This difference
was not significant statistically (OR = 1.09, 95% CI = 0.64
– 1.8; P = 0.73).
Chronic lung disease (defined as continuing need for 
supplemental oxygen at 36 wk corrected age)
After controlling for GA, among infants who survived
until 28 days of life, SGA infants were observed to be at a
significantly higher risk for developing chronic lung dis-
ease as compared to AGA infants (OR = 2.2, 95% CI = 1.2
– 3.9; P = 0.01).
Length of hospital stay
Among the infants who survived till discharge from the
hospital, SGA infants had a significantly longer hospital
stay than AGA infants (RR 1.29, 95% CI = 1.22 – 1.37, P
< 0.0001). The relationship of length of hospital stay
between SGA and AGA premature infants, stratified by
GA, is shown in the Figure 3 and Table 4.
Discussion
It is a commonly held assumption that growth restricted
fetuses are "stressed" by unfavourable in-utero  environ-
ment and have accelerated lung maturation and thus
lower incidence of pulmonary complications when com-
pared to appropriately grown infants. [15,16] However
different studies have conflicting reports on outcomes of
premature SGA infants when compared to premature
AGA infants with some reporting an increased mortality
and morbidity [1,3,4,7,8], some reporting decreased [5]
and some reporting no change in the mortality and mor-
bidity of SGA preterm infants when compared to AGA
infants. [17-19]
Regarding mortality, our study confirmed that premature
SGA neonates were at a higher risk of mortality than pre-
mature AGA infants (Odds Ratio 3.1, p = 0.001) and most
of the risk of mortality was in the lower gestational age
groups (23 – 31 weeks) as shown in the figure 1. These
findings are consistent with those observed in some of the
previous studies [3,8,20-22]. One study by Bardin et al [1]
however did not observe any significant difference in
mortality between the two groups. This study's popula-
tion however was limited to 24 – 26 weeks of GA with
only 41 SGA infants enrolled and did not represent the
complete spectrum of premature infants. A recent report
from Lal et al from a geographically defined population
has confirmed that SGA preterm infants are at higher risk
for chronic lung disease and death before 28 days of birth
and 36 weeks post-menstrual age. [23]
In our study, the premature SGA infants were observed to
be at a lower risk for RDS than premature AGA infants
(Odds ratio = 0.71, P = 0.02). Procianoy et al [5] had also
shown the incidence of RDS to be lower in SGA infants as
compared to AGA infants born ≤32 weeks of GA. However
other studies have found either no difference between the
two groups [1,3,8] or an increased incidence and severity
of RDS in premature SGA infants [7,24]. The concept of
Table 2: Distribution of study population based on gestational 
age
GA SGA (n = 358) AGA (n = 2008)
22–25 weeks 8 (2.2%) 167 (10.4%)
26–28 weeks 11 (3.1 %) 312 (15.5%)
29–31 weeks 46 (12.8%) 447 (22.3%)
32–34 weeks 161 (45%) 731 (36.4%)
35–36 weeks 132 (36.9%) 307 (15.3%)
Data shown as frequency (%)BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/9
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accelerated lung maturation in response to stress was ini-
tially proposed in 1980s [16]. The concept was supported
by data demonstrating improved biochemical pulmonary
profile in growth restricted babies [25,26]. However pos-
tulated benefits of accelerated lung maturation may be
counterbalanced by fetal hypoxemia and acidosis second-
ary to decreased utero-placental perfusion [27]. In our
population, there appears to be is a distinct GA (>32 wks)
where this balance appears to be shifted in favor of accel-
erated lung maturation and lower incidence of RDS (Fig-
ure 2).
The analysis for days on ventilator represents the severity
of initial lung disease. From our study it is clear that
despite the lower incidence of RDS in SGA infants as com-
pared to AGA infants, the total number of days on venti-
lator in both groups is not different suggesting that the
advantage of "stressed" lung is transient.
We found that SGA infants were at a slightly higher risk for
developing BPD and at a significantly higher risk of devel-
oping chronic lung disease defined at 36 wk post-men-
strual age. These findings are consistent with previous
studies [1,3,28,29] which showed premature SGA infants
to have increased incidence of BPD and/or chronic lung
disease. It needs to be emphasized that the stratification
by GA of these outcomes had not been done in these ear-
lier studies and some were limited in the population stud-
ied, by GA ≤ 32 wk [28] or by birth weight ≤ 1500 gm [29].
Etiology of chronic lung disease is multifactorial, with var-
Mortality by gestational age Figure 1
Mortality by gestational age The figure represents percent of infants that died in each gestational age group. AGA infants are 
represented by the lighter bars and SGA infants are represented by the darker bars.BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/9
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ious factors such as RDS, duration and degree of ventilator
support, higher oxygen concentration exposure of the
infant and chronic malnutrition, playing significant roles.
Chronic undernutrition, as in case of intrauterine growth
retardation, can aggravate the deficiency of antioxidants
which might predispose the infant to chronic lung disease
or make it worse [30]. Moreover, pulmonary alveolariza-
tion has been shown to be reduced by nutritional depriva-
tion in experimental animals [31]. The hypoxemia and
acidosis experienced by the fetus due to factors that
induce restricted growth may be involved in the release of
pro-inflammatory factors like Tumor Necrosis Factor-
alpha [32]. Fetal exposure to Tumor Necrosis Factor-alpha
has been shown to increase RDS and chronic lung disease
in infants [33,34].
Length of hospital stay reflects severity of illness and mor-
bidity among survivors. Our study showed that the SGA
infants had a significantly longer hospital stay than AGA
infants. This is consistent with observation made in other
studies [1-3] and can be explained by increased
complexity and severity of medical problems faced by pre-
mature SGA infants as compared to AGA infants.
RDS by gestational age Figure 2
RDS by gestational age The figure represents percent of infants who developed RDS at each gestational age. SGA infants are 
represented by dotted line and AGA infants are represented by continuous line.
Table 3: Odds of RDS in SGA/AGA infants
GA groups Odds ratio 95% CI P Value
22–25 wks 0.38 0.06 – 7.6 0.44
26–28 wks 1.55 0.28 – 29 0.66
29–31 wks 0.99 0.54 – 1.83 0.98
32–34 wks 0.62 0.44 – 1.06 0.09
35–36 wks 0.45 0.25 – 0.73 0.002*
* Statistically significantBMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/9
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Conclusions
In conclusion, our study showed that when compared to
premature AGA infants, premature SGA infants have sig-
nificantly higher risk of mortality, significantly lower risk
of RDS (though most of this benefit appears to be at GA
32–36 wks), significantly higher risk of developing
chronic lung disease and a significantly longer hospital
stay.
This study is unique in that it has utilized newer United
States gender and race specific norms to classify infants as
SGA and AGA. Also of note is that the lower incidence of
RDS in SGA infants was observed to be most significant at
the gestational ages 32–36 wks, but not at <32 wks, this
may partly explain the discrepancies observed with some
of the previous studies which studied premature infants as
a single group and/or failed to look at the outcomes at dif-
ferent gestational ages. Transient benefit of accelerated
lung maturity in premature SGA infants, as seen by lower
incidence of RDS, does not appear to influence other pul-
monary outcomes such as days on ventilator and BPD. On
the other hand compromised nutrition [30] and intrauter-
ine growth appears to play a more important role in deter-
mining long-term pulmonary morbidity such as chronic
lung disease.
Length of hospital stay Figure 3
Length of hospital stay The figure represents the total length of stay in the hospital among infants who survived to 28 days. 
AGA infants are represented by the lighter bars and SGA infants are represented by darker bars. Total numbers of infants in 
each gestational age group are shown within the bars. * indicates p < 0.05.
Table 4: Relative risk of length of hospital stay in SGA/AGA 
infants
GA groups Relative Risk 95% CI P Value
22–25 wks 0.98 0.64–1.78 0.95
26–28 wks 1.77 1.09–3.57 0.02*
29–31 wks 1.28 1.1–1.5 0.0008*
32–34 wks 1.35 0.24–1.47 <0.0001*
35–36 wks 1.21 1.1–1.35 0.0002*
* Statistically significantBMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/9
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